Viking Therapeutics completed enrollment of the VK2735 maintenance study in January and is set to report results in 3Q26.
Pooled analyses in patients with moderate Alzheimer’s show dose-related cognitive benefit and signs of durability.100% of patients remained ...
Data analysts have to use Excel and Google Sheets more or less on a daily basis in their work. Although these spreadsheet tools are often overshadowed by programming languages, the ability to analyze, ...
Advancements in pharmacogenomics and multi-omics are transforming IBS care, enabling personalized treatment strategies based ...
Objective Drug-related problems (DRPs), which encompass medication errors (MEs), adverse drug reactions and adverse drug events (ADEs), represent significant challenges in healthcare settings. While ...
The early T-shirt weather in western Montana this year comes with some costs, including ticks and other bugs waking up weeks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results